MARKET

BLRX

BLRX

Biolinerx
NASDAQ
4.700
0.000
0.00%
After Hours: 4.700 0 0.00% 16:04 07/14 EDT
OPEN
4.600
PREV CLOSE
4.700
HIGH
4.855
LOW
4.400
VOLUME
36.51K
TURNOVER
--
52 WEEK HIGH
35.60
52 WEEK LOW
2.300
MARKET CAP
17.49M
P/E (TTM)
-0.0440
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BLRX last week (0707-0711)?
Weekly Report · 20h ago
Weekly Report: what happened at BLRX last week (0630-0704)?
Weekly Report · 07/07 10:12
BioLineRx Ltd. Approves Key Proposals at Annual Meeting
TipRanks · 06/30 20:27
Weekly Report: what happened at BLRX last week (0623-0627)?
Weekly Report · 06/30 10:15
Weekly Report: what happened at BLRX last week (0616-0620)?
Weekly Report · 06/23 10:11
Where BioLine Rx Stands With Analysts
Benzinga · 06/17 12:00
BioLine RX Price Target Maintained With a $26.00/Share by HC Wainwright & Co.
Dow Jones · 06/17 11:29
Promising Phase 2 Trial Results Drive Buy Rating for BioLine RX in mPDAC Treatment
TipRanks · 06/17 10:26
More
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Webull offers BioLine RX Ltd - ADR stock information, including NASDAQ: BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.